Risk of Bleeding Associated With Outpatient Use of Rivaroxaban in VTE Management at a National Referral Hospital in Western Kenya

There is limited data on the bleeding safety profile of direct oral anticoagulants, such as rivaroxaban, in low- and middle-income country settings like Kenya. In this prospective observational study, patients newly started on rivaroxaban or switching to rivaroxaban from warfarin for the management...

Descripción completa

Detalles Bibliográficos
Autores principales: Njuguna, Dennis, Nwaneri, Francis, Prichard, Allyson C., Manji, Imran, Kigen, Gabriel, Busakhala, Naftali, Nyanje, Samuel, O’Neil, Emily, Pastakia, Sonak D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Manuscript
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350777/
https://www.ncbi.nlm.nih.gov/pubmed/37448336
http://dx.doi.org/10.1177/10760296231184216

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350777/
https://www.ncbi.nlm.nih.gov/pubmed/37448336
http://dx.doi.org/10.1177/10760296231184216

Ejemplares similares